Bradley Stringer

1.6k total citations
26 papers, 884 citations indexed

About

Bradley Stringer is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bradley Stringer has authored 26 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Bradley Stringer's work include Ubiquitin and proteasome pathways (8 papers), Microtubule and mitosis dynamics (6 papers) and Cancer-related Molecular Pathways (6 papers). Bradley Stringer is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Microtubule and mitosis dynamics (6 papers) and Cancer-related Molecular Pathways (6 papers). Bradley Stringer collaborates with scholars based in United States, United Kingdom and Canada. Bradley Stringer's co-authors include Mark Manfredi, Kara M. Hoar, Mengkun Zhang, Jessica J. Huck, Tricia J. Vos, Jeffrey Ecsedy, Katherine Galvin, Wei Chen, Olga Burenkova and Marc L. Hyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Bradley Stringer

25 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bradley Stringer United States	12	515	449	396	142	72	26	884
Xihui Yang United States	10	774 1.5×	515 1.1×	352 0.9×	312 2.2×	71 1.0×	10	1.3k
Michelle B. Crosby United States	10	777 1.5×	178 0.4×	516 1.3×	171 1.2×	24 0.3×	12	1.4k
Colin Walsh United States	12	644 1.3×	316 0.7×	266 0.7×	176 1.2×	20 0.3×	18	1.1k
Edina Komlódi-Pásztor United States	9	439 0.9×	304 0.7×	319 0.8×	78 0.5×	19 0.3×	17	793
Anna Maria Cirafici Italy	19	814 1.6×	117 0.3×	432 1.1×	158 1.1×	29 0.4×	29	1.4k
Irene Rodríguez‐Hernández Spain	15	481 0.9×	191 0.4×	279 0.7×	161 1.1×	25 0.3×	21	877
Satoko Nakada Japan	13	468 0.9×	168 0.4×	178 0.4×	158 1.1×	42 0.6×	38	970
J. Robert Grammer United States	15	529 1.0×	280 0.6×	181 0.5×	264 1.9×	24 0.3×	19	929
Kenneth R. LaMontagne United States	14	751 1.5×	150 0.3×	273 0.7×	149 1.0×	18 0.3×	21	1.1k
Severa Bunda Canada	18	608 1.2×	161 0.4×	150 0.4×	177 1.2×	24 0.3×	27	1.0k

Countries citing papers authored by Bradley Stringer

Since Specialization

Citations

This map shows the geographic impact of Bradley Stringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley Stringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley Stringer more than expected).

Fields of papers citing papers by Bradley Stringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley Stringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley Stringer. The network helps show where Bradley Stringer may publish in the future.

Co-authorship network of co-authors of Bradley Stringer

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley Stringer. A scholar is included among the top collaborators of Bradley Stringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley Stringer. Bradley Stringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stringer, Bradley, et al.. (2024). Abstract LB063: Anti-tumor activity in preclinical models utilizing a conditional bispecific redirected activation molecule (COBRA) targeting Her2. Cancer Research. 84(7_Supplement). LB063–LB063. 1 indexed citations

Nguyen, Anna, Stacey M. Bagby, Betelehem W. Yacob, et al.. (2018). Abstract B050: Evaluation of TAK-264, a novel antibody-drug conjugate in pancreatic cancer cell lines and patient-derived xenograft models. Molecular Cancer Therapeutics. 17(1_Supplement). B050–B050. 3 indexed citations

Abu‐Yousif, Adnan O., Bret Bannerman, Melissa Gallery, et al.. (2018). Abstract B120: TAK-164, a GCC-targeted antibody-drug conjugate (ADC) for the treatment of colorectal cancers and other GI malignancies. Molecular Cancer Therapeutics. 17(1_Supplement). B120–B120. 7 indexed citations

Chattopadhyay, Nibedita, Allison Berger, Erik Koenig, et al.. (2015). KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. PLoS ONE. 10(12). e0144825–e0144825. 14 indexed citations

Driscoll, Denise L., Arijit Chakravarty, Doug Bowman, et al.. (2014). Plk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines. PLoS ONE. 9(11). e111060–e111060. 45 indexed citations

Shinde, Vaishali, Bradley Stringer, Mark G. Qian, et al.. (2012). MLN0905, a Small-Molecule PLK1 Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma. Molecular Cancer Therapeutics. 11(9). 2045–2053. 16 indexed citations

Bacco, Alessandra Di, Allison Berger, Neeraj Gupta, et al.. (2012). Tumor drug distribution and target engagement of MLN9708, an investigational proteasome inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. 30(15_suppl). 3077–3077. 3 indexed citations

McDonald, Alice, Kristine Burke, Michaël Thomas, et al.. (2011). Abstract A38: Development and implementation of immunohistochemistry (IHC)-based pharmacodynamic (PD) biomarkers demonstrate NAE pathway inhibition in MLN4924 solid tumor clinical trials.. Molecular Cancer Therapeutics. 10(11_Supplement). A38–A38. 1 indexed citations

Dees, Elizabeth Claire, Jeffrey R. Infante, Roger B. Cohen, et al.. (2010). Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 67(4). 945–954. 64 indexed citations

10.

Donelan, Jill, Bret Bannerman, Paul Hales, et al.. (2009). Antitumor Activity of MLN9708, a Second-Generation Proteasome Inhibitor, in Preclinical Models of Lymphoma.. Blood. 114(22). 3724–3724. 1 indexed citations

11.

Huck, Jessica J., Arijit Chakravarty, Yu Li, et al.. (2007). Preclinical PK/PD/Efficacy relationship of MLN8054, a small molecule Aurora A kinase inhibitor. Molecular Cancer Therapeutics. 6. 2 indexed citations

12.

Stringer, Bradley, Rachel J. Waddington, Alastair J. Sloan, et al.. (2007). Serum from Postmenopausal Women Directs Differentiation of Human Clonal Osteoprogenitor Cells from an Osteoblastic toward an Adipocytic Phenotype. Calcified Tissue International. 80(4). 233–243. 17 indexed citations

13.

Manfredi, Mark, Jeffrey Ecsedy, Kristan Meetze, et al.. (2007). Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proceedings of the National Academy of Sciences. 104(10). 4106–4111. 334 indexed citations

14.

Stringer, Bradley, Rachel J. Waddington, Alastair J. Sloan, et al.. (2007). Bespoke Human Hypertrophic Chondrocytic Cell Lines Provide the Osteoinductive Signals Required for Vascularized Bone Formation. Tissue Engineering. 13(1). 133–145. 6 indexed citations

15.

Foster, George A. & Bradley Stringer. (2004). Cell-based therapies for Parkinson's disease. Drug Discovery Today Therapeutic Strategies. 1(1). 43–49. 1 indexed citations

16.

Ross, Jeffrey S., Bhaskar Kallakury, Christine E. Sheehan, et al.. (2004). Expression of Nuclear Factor-κB and IκBα Proteins in Prostatic Adenocarcinomas. Clinical Cancer Research. 10(7). 2466–2472. 110 indexed citations

17.

Stringer, Bradley, et al.. (2002). Generation of hypertrophic cartilage for bone tissue engineering. ORCA Online Research @Cardiff (Cardiff University). 2 indexed citations

18.

Foster, George A. & Bradley Stringer. (1999). Genetic Regulatory Elements Introduced Into Neural Stem and Progenitor Cell Populations. Brain Pathology. 9(3). 547–567. 5 indexed citations

19.

Oyajobi, Babatunde O., Astrid Frazer, Anthony P. Hollander, et al.. (1998). Expression of Type X Collagen and Matrix Calcification in Three-Dimensional Cultures of Immortalized Temperature-Sensitive Chondrocytes Derived from Adult Human Articular Cartilage. Journal of Bone and Mineral Research. 13(3). 432–442. 27 indexed citations

20.

McKie, Norman, Adam Houghton, Bradley Stringer, et al.. (1997). Expression of Members of a Novel Membrane Linked Metalloproteinase Family (ADAM) in Human Articular Chondrocytes. Biochemical and Biophysical Research Communications. 230(2). 335–339. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact